Federal inspectors observed the medication error at Rivers Edge Nursing and Rehab on August 13. The resident, identified as R5, had been prescribed Divalproex Sodium ER tablets specifically in extended-release form to control seizures.
The physician's orders were explicit. R5 was to receive one 250-milligram extended-release tablet each morning and two tablets each evening. The "ER" designation indicated the medication was designed to release slowly over 24 hours.
At 11:00 AM, inspectors watched as Registered Nurse J crushed one of R5's Divalproex extended-release tablets and administered it to the resident.
Extended-release medications are formulated with special coatings or matrices that control how quickly the drug enters the bloodstream. Crushing destroys this mechanism, potentially causing dangerous spikes in blood levels followed by inadequate coverage.
The facility's own policy, dated March 1, 2019, states that staff should "administer medication as ordered in accordance with manufacturer specifications" and "do not crush medications with do not crush instructions."
Divalproex, also known by the brand name Depakote, is an anti-seizure medication that requires steady blood levels to prevent breakthrough seizures. The extended-release formulation allows patients to take fewer daily doses while maintaining therapeutic levels.
When confronted an hour later, Director of Nursing B acknowledged the error immediately.
"Yes," she told inspectors when asked if staff should follow physician orders.
Asked specifically about crushing Divalproex extended-release tablets, DON B stated: "It should not be crushed or chewed."
She reviewed R5's chart and confirmed there was no physician order authorizing the crushing of the medication.
"No," she said when asked if it was acceptable for nurses to crush R5's extended-release tablets.
The medication error represented a fundamental breakdown in basic nursing practice. Extended-release medications carry clear labeling and are widely known in healthcare settings as drugs that must not be altered.
For seizure patients like R5, medication timing and dosing consistency are critical. Breakthrough seizures can cause serious injury, particularly in elderly nursing home residents who may fall and sustain fractures or head injuries.
The inspection occurred following a complaint, though the report does not specify whether the medication error was the subject of the original complaint or discovered during the investigation.
DON B told inspectors that the facility's medical director would order liquid Divalproex ER for R5, presumably to avoid future crushing incidents. However, the report provides no timeline for this change or explanation of why proper administration procedures weren't followed in the first place.
The violation was classified as causing minimal harm or potential for actual harm. Federal inspectors noted that few residents were affected, indicating this was an isolated incident involving R5's care.
Rivers Edge Nursing and Rehab's medication administration policies appeared adequate on paper. The facility had clear written guidance prohibiting the crushing of medications without specific orders. The problem was execution, not policy.
The incident raises questions about nursing supervision and competency verification at the facility. Basic medication administration principles, including recognition of extended-release formulations, are fundamental nursing skills taught in entry-level programs.
R5's seizure disorder required careful medication management. The resident was prescribed a twice-daily regimen designed to maintain steady drug levels throughout each 24-hour period. By crushing the morning dose, the nurse potentially created a dangerous situation where R5 received too much medication initially, followed by inadequate coverage later in the day.
The August inspection was conducted by federal surveyors following a complaint investigation. The medication error occurred on August 13, just twelve days before the formal inspection date of August 25.
Rivers Edge Nursing and Rehab had established policies requiring adherence to physician orders and manufacturer specifications for medication administration. The registered nurse's decision to crush R5's extended-release tablets violated both requirements simultaneously.
The facility's Director of Nursing demonstrated appropriate knowledge when questioned by inspectors, correctly identifying that the medication should not be crushed and acknowledging that no physician order authorized the alteration. This suggests the error resulted from individual nursing practice rather than systemic misunderstanding of extended-release medications.
For R5, the medication error meant receiving seizure medication in a potentially dangerous pattern, with blood levels spiking immediately after administration rather than rising gradually as intended by the extended-release formulation.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Rivers Edge Nursing and Rehab from 2025-08-25 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Rivers Edge Nursing and Rehab
- Browse all WI nursing home inspections